Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales

Novo Nordisk has cut the price of its obesity drug Ozempic in India to boost sales, with the weight-loss treatment Wegovy now selling at $50 a week. This move aims to tap into India's large obese population. The price cut is expected to increase demand for the drug.